Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism☆
References (29)
- et al.
Clinical efficacy of amiodarone as an antiarrhythmic agent
Am J Cardiol
(1976) - et al.
Effect of long-term amiodarone therapy on thyroid hormone levels and thyroid function
Am J Med
(1985) - et al.
Simultaneous determination of amiodarone and its major metabolite desethylamiodarone in plasma, urine and tissues by high-performance liquid chromatography
J Chromatogr
(1983) - et al.
Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias
Circulation
(1983) - et al.
Pharmacokinetics and body distribution of amiodarone in man
Arzneim-Forsch/Drug Res
(1984) - et al.
Recherches dans la série des benzofurannes XXXVII
- et al.
Pharmacokinetics of amiodarone after intravenous or oral administration
Eur J Clin Pharmacol
(1981) - et al.
Le risque thyroidien d'un nouveau coronaro-dilateur iodé: l'amiodarone (cordarone)
Ann Endocrinol (Paris)
(1970) - et al.
Amiodarone and thyroid hormone metabolism
- et al.
Effects of amiodarone on thyroid function in patients with ischaemic heart disease
Br Heart J
(1975)
Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxin, and thyrotropin
“Low T3 syndrome” in patients chronically treated with an iodine-containing drug, amiodarone
Clin Endocrinol
(1978)
Hyperthyroxinemia with bradycardia and normal thyrotropin secretion after chronic amiodarone administration
J Clin Endocrinol Metab
(1981)
Are selective increases in serum thyroxine (T4) due to iodinated inhibitors of T4 monodeiodination indicative of hyperthyroidism?
J Clin Endocrinol Metab
(1982)
Cited by (0)
- ☆
This work was supported by Grant 82.052 from the Dutch Heart Foundation.
Copyright © 1991 Published by Excerpta Medica Inc.